Sequoia Capital China has reportedly joined the round of AI-led medical image diagnosis firm Infervision, and Beijing-based car sharing platform Mydadao.
Sequoia Capital China joins $47m Infervision follow-on
Infervision, which specialises in AI-led medical image diagnosis solution for cancer treatment, has raised RMB300 million ($47 million) in a Series B+ round from Sequoia Capital China, Qiming Venture Partners and Genesis Capital, the China Money Network reported.
New investors Xianghe Capital Co Ltd and Advantech Capital also participated in the round.
The company raised an RMB120-million ($18-million) Series B round in September 2017 led by Qiming with participation from Sequoia and Genesis. Prior to that, it had raised its Series A round from Sequoia.
The startup has offices in the U.S., Japan, Germany and has operations around China.
Baidu, Sequoia bet on car-sharing platform Mydadao
The car-sharing platform, which was founded in late 2017, raised an undisclosed investment from three funding rounds over the past few months.
Baidu Ventures and Sequoia Capital China participated in the first two of these three funding rounds. The third investment round was led by BAI and Volcanics Venture, which focuses on the Internet, healthcare and smart technology space.
The company uses data analysis to make major decisions like selection of cities, management of parking charges and recharging of cars. The firm is led by CEO Liu Hui. It has over 2,000 cars on the roads, with the majority being electric vehicles.